BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7888227)

  • 1. Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1.
    Shpaer EG; Delwart EL; Kuiken CL; Goudsmit J; Bachmann MH; Mullins JI
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1679-84. PubMed ID: 7888227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
    De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
    Bruce C; Clegg C; Featherstone A; Smith J; Biryahawaho B; Downing R; Oram J
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1543-50. PubMed ID: 7888209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina].
    Gómez Carrillo M; Piccardo C; Libonatti O
    Rev Argent Microbiol; 1992; 24(2):91-101. PubMed ID: 1298019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1.
    Spenlehauer C; Saragosti S; Fleury HJ; Kirn A; Aubertin AM; Moog C
    J Virol; 1998 Dec; 72(12):9855-64. PubMed ID: 9811721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.
    Vancott TC; Polonis VR; Loomis LD; Michael NL; Nara PL; Birx DL
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1379-91. PubMed ID: 8573396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells.
    Holm-Hansen C; Grothues D; Rustad S; Røsok B; Pascu FR; Asjö B
    AIDS Res Hum Retroviruses; 1995 May; 11(5):597-603. PubMed ID: 7576916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
    Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120.
    Baillou A; Brand D; Denis F; M'Boup S; Chout R; Goudeau A; Barin F
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1209-15. PubMed ID: 7511395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.
    Ivanoff LA; Looney DJ; McDanal C; Morris JF; Wong-Staal F; Langlois AJ; Petteway SR; Matthews TJ
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):595-603. PubMed ID: 1768461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1.
    Mammano F; Salvatori F; Ometto L; Panozzo M; Chieco-Bianchi L; De Rossi A
    J Virol; 1995 Jan; 69(1):82-92. PubMed ID: 7527089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
    Sherefa K; Sällberg M; Sönnerborg A
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel evolution in the V3 region of HIV type 1 after infection of hemophiliacs from a homogeneous source.
    Kasper P; Kaiser R; Oldenburg J; Brackmann HH; Matz B; Schneweis KE
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1669-78. PubMed ID: 7888226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
    Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J
    J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region.
    Holm-Hansen C; Baan E; Asjö B; Pascu FR; Goudsmit J; De Jong JJ
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):867-70. PubMed ID: 10875612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1.
    Schønning K; Jansson B; Olofsson S; Hansen JE
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():753-8. PubMed ID: 8627264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the V3 loop in neutralization-resistant human immunodeficiency virus type 1 variants by direct solid-phase DNA sequencing.
    Wahlberg J; Albert J; Lundeberg J; Von Gegerfelt A; Broliden K; Utter G; Fenyö EM; Uhlén M
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):983-90. PubMed ID: 1812947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of the V3 loop regions of the env genes of Ugandan human immunodeficiency proviruses.
    Oram JD; Downing RG; Roff M; Serwankambo N; Clegg JC; Featherstone AS; Booth JC
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):605-14. PubMed ID: 1768462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1.
    Harrowe G; Cheng-Mayer C
    Virology; 1995 Jul; 210(2):490-4. PubMed ID: 7618285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.